Scientists were able to show that either both or one of the
non-coding mutations present in all
B alleles, cause an up-regulation of the activity of
CDKN2A. ). With more of the gene product, which is called
ARF (Alternate Reading frame Protein) in the cell, more of
p53 is protected from degradation.
p53 is a
transcription factor which in turn activates more
genes involved in
cell cycle regulation and
apoptosis. As a consequence the cell stops dividing and starts to prematurely produce pigment. The missense mutations in the
B1 and
B2 allele, however, have an opposite effect. Both
missense mutations lead to a malfunctioning
ARF protein, which is counteracting the effect of the higher activity of the
gene to some degree. The premature production of pigment is still obvious but less strong as observed in the
B0 allele. It is intriguing that the
missense mutation in the
B1 allele is much more disruptive for the protein function than the one in the
B2 allele and the scientists believe that this is the reason for the observed
phenotypic differences between those two
alleles. When the
melanocyte progenitor cells start to migrate up from the bottom of the follicle into the
barbs where they will make pigment, they further divide until a sufficient number of
pigment cells is achieved. As a consequence of the up-regulation of
CDKN2A, most cells will stop dividing and make new cells but instead start producing pigment- a black bar is emerging from the feather. But eventually, there will not be enough
pigment cells anymore. As they are recruited from the bottom of the feather follicle, the feather keeps on growing, creating the white bar. With the new set of pigment cells, the cyclic behavior starts again, creating alternating pigmented and apigmented bars. == Sex-linked barring mutations and melanoma ==